Effect of myoinositol on in vitro fertilization/intracytoplasmic sperm injection outcome in infertile patients with polycystic ovarian syndrome: a prospective study.
Not Applicable
Completed
- Conditions
- polycystic ovarian syndrome
- Registration Number
- JPRN-UMIN000026393
- Lead Sponsor
- Reproduction Clinic Osaka
- Brief Summary
Myoinositol supplementation on intracytoplasmic sperm injection outcome in Japanese infertile polycystic ovarian syndrome women with non-obese less-androgenic phenotype: a prospective controlled observational study K. Kitaya, Y. Takaya, R. Nishiyama, K. Yamaguchi, H. Matsubayashi, T. Takeuchi, S. Mizuta1, T. Ishikawa Clin. Exp. Obstet. Gynecol. 2019, 46(4), 549-552
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Participants with a history of hyper-sensitivity to rice products
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie myoinositol's impact on ovarian function in PCOS patients undergoing IVF/ICSI?
How does myoinositol supplementation compare to metformin in improving IVF/ICSI outcomes for Japanese PCOS patients with non-obese less-androgenic phenotype?
Are there specific biomarkers that correlate with improved IVF/ICSI success rates following myoinositol treatment in PCOS patients?
What are the potential adverse events associated with myoinositol use in non-obese less-androgenic PCOS patients during fertility treatments?
What combination therapies with myoinositol are being explored to enhance IVF/ICSI outcomes in PCOS patients?